Literature DB >> 29450754

Neural Invasion is a Significant Contributor to Peritoneal Recurrence in Signet Ring Cell Gastric Carcinoma.

Dakeun Lee1, Sang-Yong Son2, Young-Bae Kim1, Sang-Uk Han2, Hoon Hur3,4.   

Abstract

BACKGROUND: Gastric signet ring cell carcinoma (SRC) has shown a favorable outcome in early stages but has a worse prognosis than non-SRC in advanced stages. However, the cause for this stage-dependent prognostic impact has not been determined. This study aimed to compare clinicopathologic features and recurrence patterns between gastric SRC and non-SRC in a cohort of Eastern patients.
METHODS: This study reviewed the prospectively collected data of 764 patients undergoing curative resection for gastric cancer from 2005 to 2008. The demographics, clinicopathologic characteristics, disease-specific survival (DSS) rate, and recurrence-free survival (RFS) rate of the patients were analyzed.
RESULTS: The SRC patients (n = 176) had a worse prognosis than the non-SRC patients (n = 588), especially in stages T3 and T4. Peritoneal recurrence and the incidence of neural invasion (NI) were significantly increased in the SRC patients, albeit only in stages T3 and T4. In the T3 and T4 patients with NI, peritoneal recurrence occurred more frequently in SRC than in non-SRC (28.7% vs. 13.7%; p = 0.001), but not in the T3 and T4 patients without NI. Only in the patients with NI, SRC led to a significantly shorter DSS (67.6 vs. 90.7 months; p = 0.008) and RFS (67.1 vs. 80.3 months; p = 0.036) than non-SRC.
CONCLUSIONS: This report is the first to present the relationship between NI and peritoneal recurrence as the cause of stage-dependent prognoses for SRC. A better understanding of NI may lend insight into cancer spread and recurrence, especially in gastric SRC.

Entities:  

Mesh:

Year:  2018        PMID: 29450754     DOI: 10.1245/s10434-018-6371-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data.

Authors:  Bin-Bin Xu; Jun Lu; Zhi-Fang Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Gastric Cancer       Date:  2019-02-09       Impact factor: 7.701

2.  Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?

Authors:  Jiao-Bao Huang; Jun Lu; Dong Wu; Bin-Bin Xu; Zhen Xue; Guo-Sheng Lin; Hua-Long Zheng; Li-Li Shen; Jia Lin; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

3.  Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy.

Authors:  Chun Gao; Ci Dian Dan Zeng; Yi Xin Tong; Li Zhu; Sheng Zhang
Journal:  Front Surg       Date:  2022-04-01

4.  Does three-dimensional surgery affect recurrence patterns in patients with gastric cancer after laparoscopic R0 gastrectomy? Results from a 3-year follow-up phase III trial.

Authors:  Jun Lu; Bin-Bin Xu; Zhi-Fang Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Surg Endosc       Date:  2020-01-17       Impact factor: 4.584

Review 5.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

6.  Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study.

Authors:  Jun Lu; Bin-Bin Xu; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Mark J Truty; Chang-Ming Huang
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

7.  Early and late recurrences in lymph node-negative gastric cancer: a retrospective cohort study.

Authors:  Jian-Wei Sun; Dao-Li Liu; Jia-Xian Chen; Li-Zhen Lin; Lv-Ping Zhuang; Xian-Hai Hou
Journal:  Ann Saudi Med       Date:  2021-12-02       Impact factor: 1.526

8.  Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.

Authors:  Jianxian Lin; Yajun Zhao; Yanbing Zhou; Yantao Tian; Qingliang He; Junpeng Lin; Hankun Hao; Bingbing Zou; Lixin Jiang; Gang Zhao; Wei Lin; Yanchang Xu; Zhi Li; Fangqin Xue; Shuliang Li; Weihua Fu; Yongxiang Li; Zekuan Xu; Yong Li; Jinping Chen; Xiaojun Zhou; Zhenggang Zhu; Lisheng Cai; En Li; Honglang Li; Chaohui Zheng; Ping Li; Changming Huang; Jianwei Xie
Journal:  JAMA Netw Open       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.